
MSDG May 10 Monthly Meeting – Sponsored by Bruker Daltonics –
“Impact of Ultra-High Resolution Mass Spectrometry on Early Stage Developability Assessment”, and
“Intact Biotherapeutics Characterization and the Latest in Automated Biopharmaceutical Software – Biopharma Compass 2.0”